(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ABOMICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ABOMICS

ST13

US500000079341934

Class

9, 44

Filing

79341934

Registration

7292267

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

09/27/2025

Trademark type

Word

Nice classes

9, 44

Filing date

04/27/2022

Registration date

01/30/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/30/2024

Last transaction

09/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

FI

Examiner

GREENE, BYRON

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Abomics Oy

Representatives

Lisa C. Pavento Meunier Carlin & Curfman LLC

Technical classification

Nice Classes

Class 9Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer software for accessviewingrecordingtransmittingprocessingvisualization of medical datapharmacogenetic datamedicine data; Downloadable electronic databases containing structured medical datapharmacogenetic data and medicine datafor use with computer software; Downloadable computer software for authorizing access to databases in the fields of pharmacogenetics and pharmaceuticals; Downloadable electronic databases featuring medical data in the field of pharmacogeneticsfor use with computer software; Downloadable electronic databases featuring medical data in the field of pharmaceuticalsfor use with computer software; Downloadable computer software and applications for accessviewingrecordingtransmittingvisualization of medical datapharmacogenetic data and medicine data for use on mobile devices

Class 44

Providing online medical record analysis services designed to provide patients and medical professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms other than in the field of dentistry; Providing online medical record analysis services designed to provide patients and medical professionals online clinical reports with information about medical conditions other than in the field of dentistry; Pharmaceutical adviceproviding online pharmacogenetic reports other than in the field of dentistry; Pharmaceutical advice; pharmaceutical adviceproviding information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical assistance; genetic testing for medical purposes; medical evaluation services for assessing effects and effectiveness of medical substances; Medical evaluation services for interpreting genes of patients to predict which drugs have the best opportunity for positive outcomes for patientspersonalize medication selection and treatment choices for patientsidentify potentially harmful drug reactions and calculate drug dosage adjustments for patients; medical counselling; medical information; medical analysis services relating to treatment of patients; DNA screening for medical purposes; providing information relating to medical services; medical analysis for the diagnosis and treatment of persons; medical and healthcare services related to DNAgenetics and genetic testing; medical and healthcare services related to DNAgenetics and genetic testingproviding medical information to medical professionals in the form of reports in the field of pharmaceutical-gene interactions

Publications

History of USPTO decisions and trademark events.

32 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/26/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/21/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/30/2024

FIMP

FINAL DISPOSITION PROCESSED

04/30/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/30/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/30/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

11/27/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/14/2023

PUBO

PUBLISHED FOR OPPOSITION

11/14/2023

GPNX

NOTIFICATION PROCESSED BY IB

11/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/08/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

11/08/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/25/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/25/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/25/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/12/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

10/10/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/04/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/04/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/04/2023

RFNT

REFUSAL PROCESSED BY IB

04/24/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/04/2023

RFRR

REFUSAL PROCESSED BY MPU

04/04/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/16/2023

CNRT

NON-FINAL ACTION WRITTEN

02/15/2023

DOCK

ASSIGNED TO EXAMINER

02/15/2023

MAFR

APPLICATION FILING RECEIPT MAILED

06/21/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/17/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/10/2022

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

06/02/2022

Continuous trademark protection

Get notified about every new filing that threatens ABOMICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.